Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

SHP 4,874.46 +30.46 (0.63%)
price chart
Shire PLC 21.6% Potential Upside Indicated by Exane BNP Paribas
Shire PLC using EPIC/TICKER code LON:SHP has had its stock rating noted as 'Reiterates' with the recommendation being set at 'OUTPERFORM' today by analysts at Exane BNP Paribas.
Shire PLC (SHP) Stock Rating Reaffirmed by BNP Paribas  The Cerbat Gem
Shire PLC (LON:SHP) stock price target held steady at 5900.00GBX, issued a ...  Breaking Finance News
Shire PLC 4Q Earnings, Revenue Beat Street (SHPG)
Shire PLC (SHPG) announced its robust fourth-quarter and full year 2016 financial results and promising growth prospects for 2017.
Shire Plc (SHPG) Q4 2016 Results - Earnings Call Transcript  Seeking Alpha
Day Ahead: Shire the big draw with sales of new drug closely monitored  Proactive Investors UK
Shire leads the FTSE 100 as market reacts positively to results and forward ...
Drugs giant Shire Plc (LON:SHP) has set out the revenues and earnings it expects to generate in 2017 - numbers that include a first full-year contribution from its US$32bn Baxalta acquisition.
Shire profit rises 63% as sales more than double  MarketWatch
Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth  TheStreet.com
Why Shire's 2017 Guidance Is Encouraging And Should Reassure Investors
In terms of Non-GAAP EPS per ADS, the company guided for a range of $14.60-15.20. The midpoint of $ 14.90 is 2% below Bloomberg consensus of $15.20.
Shire PLC 39.1% Potential Upside Indicated by Jefferies International
Shire PLC using EPIC/TICKER code LON:SHP has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Jefferies International.
Shire PLC (LON:SHP) stock price target held steady at 5500.00GBX, issued a ...  Breaking Finance News
Shire PLC (SHP) Receives Average Rating of “Buy” from Brokerages  The Cerbat Gem
Week ahead: Shire continues pharma newsflow; Rolls-Royce results also key
Drugs will again be a focus this coming week as Shire Plc (LON:SHP) completes the fourth-quarter results announcements from the FTSE 100-listed pharma giants following numbers from peers AstraZeneca PLC (LON:AZN) and GlaxoSmithKline plc ...
Shire PLC 5% Potential Decrease Indicated by HSBC
Shire PLC using EPIC/TICKER code LON:SHP had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' today by analysts at HSBC.
Is this small-cap value stock the next Shire plc?
Shares in small-cap pharma stock Vernalis (LSE: VER) were sliding c.15% on Tuesday after the company reported worse than expected revenue figures for the half-year to December.
Shire PLC 25.6% Potential Upside Indicated by Liberum Capital
Shire PLC with EPIC/TICKER LON:SHP has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Liberum Capital.
The Shire PLC (SHP) – Analysts' Weekly Ratings Updates  DailyQuint
Shire PLC (SHP) Receives Overweight Rating from JP Morgan Chase & Co  BBNS
SHIRE PLC (NASDAQ:SHPG) Files An 8-K Other Events
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions.